We partner with curious, passionate entrepreneurs who are intent on making the healthcare system work better for everyone.
Answering high-stakes questions with RWE
CEO: Farzad Mostashari
Investor: Dave Schulte
Value-based care for primary care
CEO: Nancy Yu
Investor: Carrie Williams
Advancing rare disease treatment
CEO: David Medvedeff
Investor: Jennifer Carter
On-demand pharmacist network
CEO: Jim Gabriele
Investor: Dave Schulte
Answering the toughest questions in cancer
CEO: Feyi Olopade Ayodele
Investor: Michelle Snyder
Integrating genetic testing into routine care
CEO: Ed Seguine
Investor: Dave Schulte
Power patient outcomes
CEO: Will Saunders
Investor: Dave Schulte
Collaborative care for senior living residents.
CEO: Deborah Kilpatrick, Christine Lemke
Investor: Carrie Williams
Empowering everyone to participate in better outcomes
CEO: Tom Lee
Investor: Michelle Snyder
Reimagining primary care for all
CEO: Andrew Dudum
Investor: Tom Rodgers
Democratizing and destigmatizing healthcare
CEO: Dave Kerwar
Investor: Michelle Snyder
Bringing health care home
CEO: Doug Ghertner
Investor: Dave Schulte
Redefining the infusion experience
Reducing disease burden though smarter data
CEO: Chris Benko
Investor: Carrie Williams
Revolutionizing effect detection in clinical research
CEO: Graham Gardner
Investor: Tom Rodgers
Current Investor: Carrie Williams
Optimizing patient access and physician utilization
CEO: Douglas Lambert
Investor: Carrie Williams
Medicine cabinet for animal health
CEO: David MacMurchy
Investor: Dave Schulte
Decentralizing clinical trials from the comfort of home
Matternet is the developer of the world’s leading technology platform for on-demand aerial delivery in urban environments. The company provides its technology platform as a service to healthcare, e-commerce, and logistics organizations throughout the world. Learn More
CEO: Andreas Raptopoulos
Investor: Tom Rodgers
Current Partner: Jennifer Carter
Drone delivery for healthcare
MDSS is a collaborative program established by Merck and the New Jersey Innovation Institute, an NJIT corporation, with technology support from Microsoft and investments from the Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures. MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck. Learn More
Investor: Carrie Williams
Drug discovery accelerator
CEO: Aaron Gerber
Investor: Michelle Snyder
Value based oncology care at home
CEO: Bill Evans
Investor: Michelle Snyder
Powering the future of digital health
CEO: Julia Regan
Investor: Carrie Williams
Transforming the specialty Rx enrollment process
CEO: Dan Gilman
Investor: Michelle Snyder
Intelligently connecting biopharma and providers
CEO: Suresh Katta
Investor: Dave Schulte
Faster, safer clinical development
CEO: Chuck Ganapathi
Investor: Carrie Williams
Human friendly customer engagement
Truveris brings transparency to the prescription drug ecosystem through data driven innovations. The company’s platform offers customers — including employers, retailers, pharmacy benefits stakeholders and manufacturers — the data and insights they need to manage rising costs and market access challenges. Learn More
CEO: Nanette Oddo
Investor: Tom Rodgers
Current Partner: Dave Schulte
Maximizing the value of employer pharmacy benefits
Xealth is a digital health prescribing platform that enables clinicians to easily integrate, prescribe, and monitor digital health tools for patients from their EHR workflows, including: patient education, third-party apps and programs, device monitoring, and non-clinical services such as ride shares, food delivery, and more. Learn More
CEO: Mike McSherry
Investor: Carrie Williams
Innovative digital health prescribing platform
Investor: Tom Rodgers
Personalizing health advocacy for employees
CEO: Roy Schoenberg
Investor: Tom Rodgers
Current Partner: Jennifer Carter
Greater healthcare access at lower costs
Investor: Tom Rodgers
CRM for homecare
Investor: Tom Rodgers
Intelligent health engagement for health systems
CEO: Hans Bishop
Investor: Tom Rodgers
Current Partner: Dave Schulte
Transforming cancer care through early detection
Investor: Dave Schulte
In-home care for complex patients
CEO: Rick Dean
Investor: Dave Schulte
Navigating the complexities of cancer
Investor: Carrie Williams
Managing chronic respiratory disease better
Investor: Dave Schulte
Accelerating actionable insights across organizations
Virtual care, anytime, anywhere